These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30353760)

  • 1. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea.
    Tronstad RR; Polushina T; Brattbakk HR; Stansberg C; von Volkmann HL; Hanevik K; Ellinghaus E; Jørgensen SF; Ersland KM; Pham KD; Gilja OH; Hovdenak N; Hausken T; Vatn MH; Franke A; Knappskog PM; Le Hellard S; Karlsen TH; Fiskerstrand T
    Scand J Gastroenterol; 2018; 53(10-11):1264-1273. PubMed ID: 30353760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
    Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of guanylins are reduced in patients with Crohn's disease.
    von Volkmann HL; Brønstad I; Tronstad RR; Dizdar V; Nylund K; Hanevik K; Hausken T; Gilja OH; Fiskerstrand T
    Scand J Gastroenterol; 2020 Apr; 55(4):449-453. PubMed ID: 32306784
    [No Abstract]   [Full Text] [Related]  

  • 4. An activating gucy2c mutation causes impaired contractility and fluid stagnation in the small bowel.
    von Volkmann HL; Nylund K; Tronstad RR; Hovdenak N; Hausken T; Fiskerstrand T; Gilja OH
    Scand J Gastroenterol; 2016 Nov; 51(11):1308-15. PubMed ID: 27338166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.
    Brenna Ø; Bruland T; Furnes MW; Granlund Av; Drozdov I; Emgård J; Brønstad G; Kidd M; Sandvik AK; Gustafsson BI
    Scand J Gastroenterol; 2015; 50(10):1241-52. PubMed ID: 25979109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial diarrhea syndrome caused by an activating GUCY2C mutation.
    Fiskerstrand T; Arshad N; Haukanes BI; Tronstad RR; Pham KD; Johansson S; Håvik B; Tønder SL; Levy SE; Brackman D; Boman H; Biswas KH; Apold J; Hovdenak N; Visweswariah SS; Knappskog PM
    N Engl J Med; 2012 Apr; 366(17):1586-95. PubMed ID: 22436048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation.
    von Volkmann HL; Brønstad I; Gilja OH; R Tronstad R; Sangnes DA; Nortvedt R; Hausken T; Dimcevski G; Fiskerstrand T; Nylund K
    PLoS One; 2017; 12(9):e0185496. PubMed ID: 28957388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.
    Müller T; Rasool I; Heinz-Erian P; Mildenberger E; Hülstrunk C; Müller A; Michaud L; Koot BG; Ballauff A; Vodopiutz J; Rosipal S; Petersen BS; Franke A; Fuchs I; Witt H; Zoller H; Janecke AR; Visweswariah SS
    Gut; 2016 Aug; 65(8):1306-13. PubMed ID: 25994218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease.
    Rufini S; Ciccacci C; Di Fusco D; Ruffa A; Pallone F; Novelli G; Biancone L; Borgiani P
    Dig Liver Dis; 2015 Sep; 47(9):744-50. PubMed ID: 26066377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
    Lin Z; Hegarty JP; John G; Berg A; Wang Z; Sehgal R; Pastor DM; Wang Y; Harris LR; Poritz LS; Schreiber S; Koltun WA
    Dig Dis Sci; 2013 Sep; 58(9):2599-607. PubMed ID: 23709157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between nucleotide oligomerisation domain two (Nod2) gene polymorphisms and canine inflammatory bowel disease.
    Kathrani A; Lee H; White C; Catchpole B; Murphy A; German A; Werling D; Allenspach K
    Vet Immunol Immunopathol; 2014 Sep; 161(1-2):32-41. PubMed ID: 25017709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.
    Ballester V; Guo X; Vendrell R; Haritunians T; Klomhaus AM; Li D; McGovern DP; Rotter JI; Torres EA; Taylor KD
    PLoS One; 2014; 9(9):e108204. PubMed ID: 25259511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease genetics: Nod2.
    Cho JH; Abraham C
    Annu Rev Med; 2007; 58():401-16. PubMed ID: 16987083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease.
    André MF; Aumaître O; Piette JC; Grateau G; Cardoso MC; Ouchchane L; Kémény JL; Dastugue B; Delpech M; Creveaux I
    Dig Dis Sci; 2008 Feb; 53(2):490-9. PubMed ID: 17570063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.